Trial Profile
A Phase I Clinical Trial to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Apr 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Rosuvastatin (Primary)
- Indications Atherosclerosis; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia type II; Hypertriglyceridaemia; Sitosterolaemia
- Focus Pharmacokinetics
- Acronyms NVP-1205
- Sponsors Navipharm
- 24 Mar 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 17 Nov 2014 New trial record